Periodic Reporting for period 1 - BEndTarG (Brain Endothelium - TARgeted Gene therapy to improve Aβ clearance in Alzheimer’s Disease)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with no cure and limited treatment options. It is the most common cause of dementia, and its prevalence is expected to double in Europe by 2050 due to the ageing population. Despite significant research...